Two Sigma Advisers
STIM icon

Two Sigma Advisers’s Neuronetics STIM Stock Holding History

Two Sigma Advisers’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-169,000
Closed -$233K – 1868
2025
Q4 		$233K Buy
169,000
+64,800
+62% +$136K ﹤0.01% 2065
2025
Q3 		$284K Sell
104,200
-53,200
-34% -$189K ﹤0.01% 2010
2025
Q2 		$549K Sell
157,400
-71,000
-31% -$280K ﹤0.01% 1706
2025
Q1 		$841K Buy
+228,400
New +$834K ﹤0.01% 1549
2024
Q3 		– Sell
-43,800
Closed -$78.8K – 2516
2024
Q2 		$78.8K Sell
43,800
-6,800
-13% -$19.6K ﹤0.01% 2334
2024
Q1 		$241K Sell
50,600
-400
-0.8% -$1.41K ﹤0.01% 2150
2023
Q4 		$148K Sell
51,000
-82,600
-62% -$130K ﹤0.01% 2280
2023
Q3 		$180K Sell
133,600
-72,400
-35% -$127K ﹤0.01% 2116
2023
Q2 		$443K Sell
206,000
-17,400
-8% -$42.2K ﹤0.01% 1854
2023
Q1 		$650K Sell
223,400
-7,600
-3% -$38.3K ﹤0.01% 1831
2022
Q4 		$1.59M Buy
231,000
+44,000
+24% +$208K ﹤0.01% 1354
2022
Q3 		$595K Buy
187,000
+62,100
+50% +$226K ﹤0.01% 1771
2022
Q2 		$401K Sell
124,900
-7,400
-6% -$21.5K ﹤0.01% 2019
2022
Q1 		$401K Sell
132,300
-83,700
-39% -$283K ﹤0.01% 2090
2021
Q4 		$963K Sell
216,000
-133,000
-38% -$651K ﹤0.01% 1574
2021
Q3 		$2.29M Buy
349,000
+214,000
+159% +$2.05M 0.01% 1176
2021
Q2 		$2.16M Buy
135,000
+6,500
+5% +$89.8K 0.01% 1265
2021
Q1 		$1.59M Buy
+128,500
New +$1.97M ﹤0.01% 1388
2020
Q4 		– Sell
-21,100
Closed -$103K – 2576
2020
Q3 		$103K Sell
21,100
-121,500
-85% -$461K ﹤0.01% 2274
2020
Q2 		$275K Buy
142,600
+10,200
+8% +$20.9K ﹤0.01% 2156
2020
Q1 		$250K Buy
132,400
+109,300
+473% +$342K ﹤0.01% 2091
2019
Q4 		$104K Buy
+23,100
New +$144K ﹤0.01% 2248

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers's STIM Position: Q1 2026 in Review

Two Sigma Advisers sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 169,000 shares — an estimated $233K sold.

Two Sigma Advisers first reported a position in STIM in Q4 2019 and held it in 22 quarters. The position peaked at $2.29M in Q3 2021. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Two Sigma Advisers reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 169,000 Neuronetics shares in Q1 2026, an estimated $233K.
  • Two Sigma Advisers first reported a position in Neuronetics in Q4 2019 and held it in 22 quarters.
  • Two Sigma Advisers's Neuronetics position peaked at $2.29M in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.